Description
5-Amino-1MQ is a pathway-specific small-molecule research compound utilized for investigating nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism and methylation-related biochemical pathways. NNMT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to nicotinamide, influencing intracellular nicotinamide availability and interacting with NAD-associated metabolic processes. Through selective inhibition of NNMT activity, 5-Amino-1MQ serves as a valuable research tool for examining enzyme regulation, metabolic pathway interactions, and cellular signaling dynamics within controlled laboratory environments. Research investigations involving 5-Amino-1MQ frequently explore enzyme inhibition mechanisms, nicotinamide metabolism, NAD-related pathways, metabolic signaling networks, methylation-associated biochemical processes, and cellular energy metabolism.
Key Highlights
Product Name: 5-Amino-1MQ
Strength: 50MG
Chemical Name: 5-Amino-1-methylquinolinium
CAS Number: 685079-15-6
Molecular Formula: C₁₀H₁₁N₂⁺
Molecular Weight: 159.21 g/mol
Appearance: Yellow–Orange Crystalline Solid
Classification: Small-Molecule NNMT Inhibitor
Purity: Verified by analytical testing prior to release
Analytical Methods: HPLC, Mass Spectrometry (MS)
Research Applications
Research areas commonly associated with this compound include:
Metabolic & weight research
Storage & Handling
By purchasing from BioRogue Peptides, the purchaser acknowledges that all products are being acquired solely for lawful research purposes and will be handled in accordance with applicable regulations and accepted laboratory practices.
The purchaser assumes responsibility for the proper handling, storage, and use of all materials. BioRogue Peptides makes no representations, warranties, or claims regarding any application beyond legitimate research use.
HEALTH CANADA WARNING
Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. They may contain high-risk ingredients, such as prescription or controlled drugs, and additives or contaminants that may or may not be listed on the label. The level of active ingredients could be higher or lower than claimed and these ingredients could interact with other medications and foods. Prescription drugs should only be used under the care of a licensed health care professional because they are intended to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription.
